2 results match your criteria: "Shaoxing Yuecheng District People's Hospital[Affiliation]"
Real-world safety evaluation of brivaracetam: insights from the US FDA adverse event reporting system.
Expert Opin Drug Saf
January 2025
Shaoxing Yuecheng District People's Hospital, Shaoxing, China.
Background: Brivaracetam (BRV) is a novel drug for the treatment of epilepsy. This study aimed to detect and characterize adverse events (AEs) associated with BRV from the first quarter of 2016 to the second quarter of 2024 using the U.S.
View Article and Find Full Text PDFA study on the causal relationship between the gut microbiome and herpes zoster using Mendelian randomization.
Front Med (Lausanne)
August 2024
Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.
Article Synopsis
- The study explores the relationship between herpes zoster (HZ) recurrence and the gut microbiome, finding a potentially bidirectional causal link for the first time.
- It highlights the high global incidence of HZ, which can lead to severe symptoms and is often linked to aging and conditions like inflammatory bowel diseases.
- Utilizing data from large-scale genome studies, the research employs bidirectional Mendelian randomization to clarify how gut bacteria may influence the development of HZ and vice versa.